SCM
BMRN icon

Sio Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Sio Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-194,226
Closed -$11M – 62
2026
Q1 		$11M Sell
194,226
-38,462
-17% -$2.24M 1.57% 22
2025
Q4 		$13.8M Buy
232,688
+7,574
+3% +$412K 2.18% 15
2025
Q3 		$12.2M Hold
225,114
– – 3.09% 11
2025
Q2 		$12.4M Buy
225,114
+83,980
+60% +$4.95M 4.73% 8
2025
Q1 		$9.98M Buy
+141,134
New +$9.49M 2.97% 11
2021
Q1 		– Sell
-100,844
Closed -$8.84M – 94
2020
Q4 		$8.84M Sell
100,844
-93,900
-48% -$7.44M 1.81% 17
2020
Q3 		$14.8M Buy
+194,744
New +$19.7M 2.93% 12

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Sio Capital Management's BMRN Position: Q2 2026 in Review

Sio Capital Management sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2026, closing a stake of 194,226 shares — an estimated $11M sold.

Sio Capital Management first reported a position in BMRN in Q3 2020 and held it in 7 quarters. The position peaked at $14.8M in Q3 2020. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Sio Capital Management reported no remaining BioMarin Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sio Capital Management sold 194,226 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $11M.
  • Sio Capital Management first reported a position in BioMarin Pharmaceuticals in Q3 2020 and held it in 7 quarters.
  • Sio Capital Management's BioMarin Pharmaceuticals position peaked at $14.8M in Q3 2020.
  • 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.